2019 Chicago International Breast Course
Advancing the Art of Breast Imaging
A comprehensive breast imaging course for breast imaging radiologists, surgeons, oncologists, radiologic technologists, and other physicians and health care providers dedicated to breast care.
IMPORTANT NOTE: This course expires July 1, 2022
If you want credit, this course must be completed (i.e. view course content PDF file), pass the posttest, AND print the certificate)
by no later than 5PM Eastern Standard Time on June 30, 2022
Please note, after this course has expired, no aspect of the course will be accessible, including the course material.
Format: On-demand Conference Session
MD Credit: 2.0 AMA PRA Category 1 / Fee: $50.00
RT Credit: 2.25 ARRT Category A / Fee: $33.75
MODALITY-SPECIFIC CREDIT HOURS
Conference Overview
The 2019 Chicago International Breast Course (CIBC) offered training using cutting-edge technology with an advanced but practical approach. The three-day conference comprehensively covered breast imaging modalities, including digital breast tomosynthesis, handheld and automated whole breast US, fast-sequence MRI, and molecular breast imaging. Course topics included breast cancer screening and high-risk management controversies, quality and safety, patient engagement, clinical practice concerns, and the use of AI in breast image interpretation.
Session I: Breast Cancer Screening
1.1 Why are Screening Mammography Guidelines Controversial?
Stephen A. Feig, MD, FACR, FSBI
University of California Irvine
Irvine, CA
1.2 Can Population-based and Personalized Screening Coexist?
Stamatia Destounis, MD, FACR, FSBI, FAIUM
Elizabeth Wende Breast Care
Rochester, NY
1.3 Abbreviated MRI for Screening
Gillian M. Newstead, MD, FACR
The University of Chicago
Chicago, IL
(Handout Not Available per Faculty Request)
1.4 Supplemental Screening Modalities: What Kinds of Cancers Do We Find?
Stephen A. Feig, MD, FACR
University of California Irvine
Irvine, CA
(Handout Not Available per Faculty Request)
Conference Objectives
At the conclusion of this course, participants will be better able to:
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Chicago Pritzker School of Medicine, the International Center for Postgraduate Medical Education (ICPME), and NorthShore University HealthSystem. The University of Chicago Pritzker School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Physician Continuing Medical Education
University of Chicago Pritzker School of Medicine designates this enduring activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
SA-CME: This activity meets the criteria for self-assessment toward the purpose of fulfilling requirements in the American Board of Radiology (ABR) Maintenance of Certification Program.
The European Accreditation Council for CME (EACCME®)
The UEMS-EACCME® has mutual recognition agreements with the American Medical Association (AMA) for live event and e-learning materials.
For more information go to https://www.uems.eu/areas-of-expertise/cme-cpd/eaccme/mutual-recognition-with-the-united-states
Radiologic Technologists
This program has been approved by the American Society of Radiologic Technologists (ASRT) for 2.25 hours of ARRT Category A continuing education credit.
Tuition
Tuition for this course includes:
ICPME accepts American Express, MasterCard, and Visa.
Please note: tuition payments are non-refundable.
How to Enroll and Participate
Estimated time to complete this activity is 2.25 hours.
How to Receive Credit
Your online account with ICPME serves as a permanent record of credit certificates earned through www.icpme.us.
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity. Additionally, The University of Chicago Pritzker School of Medicine requires Faculty to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration at first mention and where appropriate in the content. Disclosure Information The staff of the Center for Continuing Medical Education at the University of Chicago and ICPME planners and managers have no disclosures. |
|
Disclosure of Unlabled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.
The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
QUESTIONS?
For questions regarding this program email: information@icpmed.com
Disclaimer
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.